Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Dec;2(4):267-275.
doi: 10.18383/j.tom.2016.00181.

Semiautomated Workflow for Clinically Streamlined Glioma Parametric Response Mapping

Affiliations

Semiautomated Workflow for Clinically Streamlined Glioma Parametric Response Mapping

Lauren Keith et al. Tomography. 2016 Dec.

Abstract

Management of glioblastoma multiforme remains a challenging problem despite recent advances in targeted therapies. Timely assessment of therapeutic agents is hindered by the lack of standard quantitative imaging protocols for determining targeted response. Clinical response assessment for brain tumors is determined by volumetric changes assessed at 10 weeks post-treatment initiation. Further, current clinical criteria fail to use advanced quantitative imaging approaches, such as diffusion and perfusion magnetic resonance imaging. Development of the parametric response mapping (PRM) applied to diffusion-weighted magnetic resonance imaging has provided a sensitive and early biomarker of successful cytotoxic therapy in brain tumors while maintaining a spatial context within the tumor. Although PRM provides an earlier readout than volumetry and sometimes greater sensitivity compared with traditional whole-tumor diffusion statistics, it is not routinely used for patient management; an automated and standardized software for performing the analysis and for the generation of a clinical report document is required for this. We present a semiautomated and seamless workflow for image coregistration, segmentation, and PRM classification of glioblastoma multiforme diffusion-weighted magnetic resonance imaging scans. The software solution can be integrated using local hardware or performed remotely in the cloud while providing connectivity to existing picture archive and communication systems. This is an important step toward implementing PRM analysis of solid tumors in routine clinical practice.

Keywords: diffusion; glioma; parametric response mapping.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: BDR has financial interest in Imbio, LLC. BDR and TLC are eligible to receive royalties using this technology.

Figures

Figure 1.
Figure 1.
Software workflow is presented for processing and analysis of serial glioma diffusion data for parametric response mapping of apparent diffusion coefficients maps (PRMADC). Images are first processed to generate an apparent diffusion coefficient (ADC) map and tumor segmentation. Then, follow-up images are spatially aligned with baseline images. Once ADC maps are aligned, they are further processed into a parametric response map, consisting of 3-voxel classifications: increased, decreased and unchanged ADC. Summary statistics for clinical evaluation consist of the tumor-relative volume of each classification as well as mean ADC at each time point.
Figure 2.
Figure 2.
Example final report of parametric response mapping (PRM) results from the online software platform. This provides PRM-relative volumes as summary statistics along with key PRM overlays and scatterplot for insight into distribution patterns and spatial context. In addition, measures of mean tumor ADC and tumor volume are provided.
Figure 3.
Figure 3.
An example of automated segmentation reveals good agreement with the original manual segmentation. Manual segmentations drawn by an experienced radiologist are shown in the top row and semiautomated segmentation results in the second row. Generation of the semiautomated VOI began with the single-slice seed ROI shown in the bottom row (slice 13).
Figure 4.
Figure 4.
Dice coefficients comparing semiautomated tumor segmentations to radiologist-defined segmentations. Maximum Dice per patient resulted in good agreement between segmentations, left; however, use of all slice ROIs individually as seed regions resulted in poor agreement, right. This indicates that seed ROI positioning is critical for an acceptable segmentation. The seed ROI should be placed in the middle of a tumor, where the tumor area is the largest.
Figure 5.
Figure 5.
Robustness of semiautomated segmentation was evaluated using Dice coefficients between the best-slice seed segmentation and shifted-seed segmentations (A), showing little variation between segmentations. Resulting volumes were also found to remain consistent with varying segmentation seed (B).
Figure 6.
Figure 6.
Receiver operator curve (ROC) analysis was used to compare final PRMADC+ results against the same subjects' previous results (n = 49). Semiautomated segmentation was performed on previously coregistered images, followed by automated PRM classification. The ROC statistics are compared between the 2 in the table.
Figure 7.
Figure 7.
The ROC analysis was used to compare final PRMADC+ results against the same subjects' previous results (n = 40). The full workflow was applied to available original imaging data, consisting of semiautomated segmentation, image coregistration, and PRM classification. ROC statistics are compared between the 2 in the table.

Similar articles

Cited by

References

    1. Ostrom QT, Gittleman H, Fulop J, Liu M, Blanda R, Kromer C, Wolinsky Y, Kruchko C, Barnholtz-Sloan JS. CBTRUS Statistical Report: primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2008-2012. Neuro Oncol. 2015;17(4):iv1–iv62. - PMC - PubMed
    1. Stupp R, Hegi ME, Mason WP, van den Bent MJ, Taphoorn MJ, Janzer RC, Ludwin SK, Allgeier A, Fisher B, Belanger K, Hau P, Brandes AA, Gijtenbeek J, Marosi C, Vecht CJ, Mokhtari K, Wesseling P, Villa S, Eisenhauer E, Gorlia T, Weller M, Lacombe D, Cairncross JG, Mirimanoff RO, European Organisation for R, Treatment of Cancer Brain T, Radiation Oncology G, National Cancer Institute of Canada Clinical Trials Group. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol. 2009;10(5):459–466. - PubMed
    1. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn U, Curschmann J, Janzer RC, Ludwin SK, Gorlia T, Allgeier A, Lacombe D, Cairncross JG, Eisenhauer E, Mirimanoff RO, European Organisation for R, Treatment of Cancer Brain T, Radiotherapy G, National Cancer Institute of Canada Clinical Trials Group. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med. 2005;352(10):987–996. - PubMed
    1. Bush NA, Chang SM, Berger MS. Current and future strategies for treatment of glioma. Neurosurg Rev. 2016. April 16. doi: 10.1007/s10143-016-0709-8 [Epub ahead of print]. - DOI - PubMed
    1. Macdonald DR, Cascino TL, Schold SC Jr., Cairncross JG. Response criteria for phase II studies of supratentorial malignant glioma. J Clin Oncol. 1990;8(7):1277–1280. - PubMed

LinkOut - more resources